Skip to content

Clinical trials

Inflammation trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Country / region: Japan Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20092
20131
20171
20191
20202
20211
20222
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status3
Recruiting2
Active, not recruiting1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S2
Aichi Gakuin University1
Amgen1
AstraZeneca1
CSL Behring1
Federal University of São Paulo1
Keio University1
Kurume University1
Kyoto University, Graduate School of Medicine1
National Defense Medical College, Japan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation16
Atherosclerosis2
Renal Insufficiency, Chronic2
Atrial Fibrillation1
Autoimmune Diseases1
Breast Neoplasms1
Coronary Artery Disease1
Crohn Disease1
Dermatitis1
Dermatitis, Atopic1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.